Conformational differences between surface-bound and fluid-phase complement-component-C3 fragments. Epitope mapping by cDNA expression
- PMID: 1372802
- PMCID: PMC1130846
- DOI: 10.1042/bj2820715
Conformational differences between surface-bound and fluid-phase complement-component-C3 fragments. Epitope mapping by cDNA expression
Abstract
In previous studies a subset of complement-component-C3 (C3) epitopes, C3(D), expressed in denatured and surface-bound C3 and C3 fragments, has been described. These epitopes were detected by antibodies raised against denatured C3. In the present study we used a cDNA expression strategy to localize epitopes recognized by monoclonal and polyclonal anti-C3(D) antibodies. First, DNAse I digestion of C3 cDNA was used to generate 200-300 bp fragments. These cDNA fragments were expressed as beta-galactosidase-C3 fusion proteins using the lambda gt11 vector. The fusion proteins were tested by Western-blot analysis for reactivity with monoclonal and polyclonal anti-C3 antibodies, and the location of the epitopes were determined by sequencing the cDNA fragments. Affinity-purified polyclonal anti-C3(D) antibodies specific for denatured C3 reacted strongly with the C3 fusion fragments corresponding to segments of the 40 kDa subunit of C3c (residues 1477-1510) and the C3d fragment (residues 1117-1155 and 1234-1294) of C3. Adsorption of the polyclonal antibodies with a mixture of EAC3b and EAC3bi (degradation fragments of C3 bound to sheep erythrocytes) abolished binding to fusion proteins spanning the C3d region, but not the 40 kDa fragment of C3c. No effect was seen with the corresponding soluble C3 fragments. The monoclonal anti-C3(D) antibodies (mAbs) 7D326.1 and 7D331.1, specific for EAC3b and EAC3bi, bound to a fusion protein corresponding to amino acid residues 1312-1404, whereas mAb 7D9.2, specific for EAC3d, reacted with a fusion protein spanning amino acid residues 1082-1118. mAbs 4SD11.1 and 4SD18.1, which did not bind to any physiological C3 fragment, detected a fusion protein covering residues 1477-1510. In summary, the segments of C3 represented by amino acid residues 1082-1118, 1117-1155, 1234-1294 and 1312-1404 accommodate C3(D) epitopes that are expressed by erythrocyte-bound C3 fragments, but not by the corresponding fluid-phase fragment, whereas the segments spanning residues 973-1026 and 1477-1510 contain C3(D) epitopes that are exposed exclusively in denatured C3 and therefore hidden in physiological fragments of the protein.
Similar articles
-
Neoantigens in complement component C3 as detected by monoclonal antibodies. Mapping of the recognized epitopes by synthetic peptides.Biochem J. 1990 May 15;268(1):55-61. doi: 10.1042/bj2680055. Biochem J. 1990. PMID: 1693076 Free PMC article.
-
Production of mouse monoclonal antibodies that detect distinct neoantigenic epitopes on bound C3b and iC3b but not on the corresponding soluble fragments.Mol Immunol. 1987 May;24(5):487-94. doi: 10.1016/0161-5890(87)90023-x. Mol Immunol. 1987. PMID: 2443836
-
Disruption of the internal thioester bond in the third component of complement (C3) results in the exposure of neodeterminants also present on activation products of C3. An analysis with monoclonal antibodies.J Immunol. 1988 Sep 1;141(5):1602-9. J Immunol. 1988. PMID: 2457622
-
Activation-dependent antigenic changes of human C3.Complement Inflamm. 1989;6(3):205-18. doi: 10.1159/000463094. Complement Inflamm. 1989. PMID: 2472922 Review.
-
Studies of C3d,g in normal human epidermal basement membrane.J Invest Dermatol. 1990 Jun;94(6 Suppl):122S-127S. doi: 10.1111/1523-1747.ep12876085. J Invest Dermatol. 1990. PMID: 2191048 Review.
Cited by
-
A Robust Method to Store Complement C3 With Superior Ability to Maintain the Native Structure and Function of the Protein.Front Immunol. 2022 May 3;13:891994. doi: 10.3389/fimmu.2022.891994. eCollection 2022. Front Immunol. 2022. PMID: 35592325 Free PMC article.
-
Evidence for iC3 generation during cardiopulmonary bypass as the result of blood-gas interaction.Clin Exp Immunol. 1993 Mar;91(3):404-9. doi: 10.1111/j.1365-2249.1993.tb05916.x. Clin Exp Immunol. 1993. PMID: 8443963 Free PMC article.
-
Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c.Immunology. 1994 Apr;81(4):648-54. Immunology. 1994. PMID: 7518801 Free PMC article.
-
A DeImmunized chimeric anti-C3b/iC3b monoclonal antibody enhances rituximab-mediated killing in NHL and CLL cells via complement activation.Cancer Immunol Immunother. 2005 Dec;54(12):1172-9. doi: 10.1007/s00262-005-0686-1. Epub 2005 Apr 22. Cancer Immunol Immunother. 2005. PMID: 15846490 Free PMC article.
-
Two conformational forms of target-bound iC3b that distinctively bind complement receptors 1 and 2 and two specific monoclonal antibodies.Ups J Med Sci. 2011 Mar;116(1):26-33. doi: 10.3109/03009734.2010.528465. Epub 2010 Nov 11. Ups J Med Sci. 2011. PMID: 21070093 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous